Related references
Note: Only part of the references are listed.HPV16 Seropositivity and Subsequent HPV16 Infection Risk in a Naturally Infected Population: Comparison of Serological Assays
Shih-Wen Lin et al.
PLOS ONE (2013)
Low risk of type-specific carcinogenic HPV re-appearance with subsequent cervical intraepithelial neoplasia grade 2/3
Ana Cecilia Rodriguez et al.
INTERNATIONAL JOURNAL OF CANCER (2012)
Smoking as a Risk Factor for STI Diagnosis Among African American Females
Carla J. Berg et al.
AMERICAN JOURNAL OF HEALTH BEHAVIOR (2012)
Early Natural History of Incident, Type-Specific Human Papillomavirus Infections in Newly Sexually Active Young Women
Rachel L. Winer et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2011)
The known unknowns of HPV natural history
Patti E. Gravitt
JOURNAL OF CLINICAL INVESTIGATION (2011)
A Competitive Serological Assay Shows Naturally Acquired Immunity to Human Papillomavirus Infections in the Guanacaste Natural History Study
Nicolas Wentzensen et al.
JOURNAL OF INFECTIOUS DISEASES (2011)
The Role of Sexual Behavior and Human Papillomavirus Persistence in Predicting Repeated Infections with New Human Papillomavirus Types
Anna-Barbara Moscicki et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2010)
Human Papillomavirus Infection and Reinfection in Adult Women: the Role of Sexual Activity and Natural Immunity
Helen Trottier et al.
CANCER RESEARCH (2010)
Cervical Human Papillomavirus Prevalence in 5 Continents: Meta-Analysis of 1 Million Women with Normal Cytological Findings
Laia Bruni et al.
JOURNAL OF INFECTIOUS DISEASES (2010)
Longitudinal Study of Human Papillomavirus Persistence and Cervical Intraepithelial Neoplasia Grade 2/3: Critical Role of Duration of Infection
Ana Cecilia Rodriguez et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2010)
Epidemiological Study of Anti-HPV16/18 Seropositivity and Subsequent Risk of HPV16 and -18 Infections
Mahboobeh Safaeian et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2010)
High-Risk Human Papillomavirus Reactivation in Human Immunodeficiency Virus-Infected Women Risk Factors for Cervical Viral Shedding
Regan N. Theiler et al.
OBSTETRICS AND GYNECOLOGY (2010)
Prevalence and stability of antibodies to 37 human papillomavirus types - A population-based longitudinal study
Annika Antonsson et al.
VIROLOGY (2010)
Cell-Mediated Immune Responses to Human Papillomavirus 16 E6 and E7 Antigens as Measured by Interferon Gamma Enzyme-Linked Immunospot in Women With Cleared or Persistent Human Papillomavirus Infection
Sepideh Farhat et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2009)
Antibody Responses in Oral Fluid after Administration of Prophylactic Human Papillomavirus Vaccines
Ali Rowhani-Rahbar et al.
JOURNAL OF INFECTIOUS DISEASES (2009)
Persistent Antibodies to HPV Virus-Like Particles Following Natural Infection Are Protective Against Subsequent Cervicovaginal Infection with Related and Unrelated HPV
Zainab A. Malik et al.
VIRAL IMMUNOLOGY (2009)
Seroprevalence of 34 human papillomavirus types in the German general population
Kristina M. Michael et al.
PLOS PATHOGENS (2008)
Determination of cytokine protein levels in cervical mucus samples from young women by a multiplex immunoassay method and assessment of correlates
Jay A. Lieberman et al.
CLINICAL AND VACCINE IMMUNOLOGY (2008)
Serologic response to oncogenic human papillomavirus types in male and female university students in Busan, South Korea
Gary M. Clifford et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2007)
Covariates of cervical cytokine mRNA expression by real-time PCR in adolescents and young women:: Effects of Chlamydia trachomatis infection, hormonal contraception, and smoking
ME Scott et al.
JOURNAL OF CLINICAL IMMUNOLOGY (2006)
Effects of 17β-estradiol and progesterone on transcription of human papillomavirus 16 E6/E7 oncogenes in CaSki and SiHa cell lines
M Ruutu et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2006)
Multiplex human papillomavirus serology based on in situ-purified glutathione S-transferase fusion proteins
T Waterboer et al.
CLINICAL CHEMISTRY (2005)
Seroreactivity to human papillomavirus (HPV) types 16, 18, or 31 and risk of subsequent HPV infection: Results from a population-based study in Costa Rica
RP Viscidi et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2004)
Regression of low-grade squamous intra-epithelial lesions in young women
AB Moscicki et al.
LANCET (2004)
Risk factors for subsequent cervicovaginal human papillomavirus (HPV) infection and the protective role of antibodies to HPV-16 virus-like particles
GYF Ho et al.
JOURNAL OF INFECTIOUS DISEASES (2002)
Risks for incident human papillomavirus infection and low-grade squamous intraepithelial lesion development in young females
AB Moscicki et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2001)
Comparison of human papillomavirus types 16, 18, and 6 capsid antibody responses following incident infection
JJ Carter et al.
JOURNAL OF INFECTIOUS DISEASES (2000)
Share Paper
